MICHAEL KUREK: Open Payments
NPI 1972099646 · SARATOGA SPRINGS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,219 in 69 payments from 13 companies in 2025. Trend: 2023 $1,434 · 2024 $2,351 · 2025 $1,219
Food & beverage: $1,219
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $354 |
| Novartis Pharmaceuticals Corporation | 21 | $342 |
| Janssen Biotech, Inc. | 7 | $181 |
| Regeneron Healthcare Solutions, Inc. | 4 | $123 |
| LEO Pharma Inc. | 2 | $44 |
| Arcutis Biotherapeutics, Inc. | 2 | $35 |
| PFIZER INC. | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| GENZYME CORPORATION | 1 | $22 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $18 |
Products named: COSENTYX, SKYRIZI, TREMFYA, DUPIXENT, RINVOQ, Rhapsido, Zoryve, CIBINQO.
Industry payments across NY — which companies pay providers there.
